94 related articles for article (PubMed ID: 10085671)
1. Oral granisetron as prophylaxis for nausea and vomiting during fluorescein angiography. A multicentre, double-blind, randomised, parallel group, placebo-controlled study.
Mattioli V; Calò A; Pisoni G; Ancona G; Zollino D; Brunetti P
Minerva Anestesiol; 1998 Dec; 64(12):553-61. PubMed ID: 10085671
[TBL] [Abstract][Full Text] [Related]
2. Anti-emetic efficacy of prophylactic granisetron, droperidol and metoclopramide in the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled trial.
Fujii Y; Saitoh Y; Tanaka H; Toyooka H
Eur J Anaesthesiol; 1998 Mar; 15(2):166-71. PubMed ID: 9587723
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
[TBL] [Abstract][Full Text] [Related]
4. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
Ettinger DS; Eisenberg PD; Fitts D; Friedman C; Wilson-Lynch K; Yocom K
Cancer; 1996 Jul; 78(1):144-51. PubMed ID: 8646710
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic antiemetic efficacy of granisetron in patients with and without previous postoperative emesis.
Fujii Y; Tanaka H; Toyooka H
Can J Anaesth; 1997 Mar; 44(3):273-7. PubMed ID: 9067046
[TBL] [Abstract][Full Text] [Related]
6. Preoperative oral granisetron for the prevention of postoperative nausea and vomiting after breast surgery.
Fujii Y; Tanaka H; Kawasaki T
Eur J Surg; 2001 Mar; 167(3):184-7. PubMed ID: 11316402
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
[TBL] [Abstract][Full Text] [Related]
8. Prevention of postoperative nausea and vomiting with granisetron: a randomized, double-blind comparison with droperidol.
Fujii Y; Tanaka H; Toyooka H
Can J Anaesth; 1995 Oct; 42(10):852-6. PubMed ID: 8706192
[TBL] [Abstract][Full Text] [Related]
9. Granisetron reduces the incidence and severity of nausea and vomiting after laparoscopic cholecystectomy.
Fujii Y; Tanaka H; Toyooka H
Can J Anaesth; 1997 Apr; 44(4):396-400. PubMed ID: 9104522
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
Spitzer TR; Friedman CJ; Bushnell W; Frankel SR; Raschko J
Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic antiemetic therapy with granisetron-droperidol combination in patients undergoing laparoscopic cholecystectomy.
Fujii Y; Saitoh Y; Tanaka H; Toyooka H
Can J Anaesth; 1998 Jun; 45(6):541-4. PubMed ID: 9669007
[TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of granisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies.
Gan TJ; Candiotti KA; Klein SM; Rodriguez Y; Nielsen KC; White WD; Habib AS
Can J Anaesth; 2009 Nov; 56(11):829-36. PubMed ID: 19730966
[TBL] [Abstract][Full Text] [Related]
13. Granisetron reduces postoperative nausea and vomiting throughout menstrual cycle.
Fujii Y; Tanaka H; Toyooka H
Can J Anaesth; 1997 May; 44(5 Pt 1):489-93. PubMed ID: 9161742
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, parallel-group, placebo-controlled, dose-ranging, multicenter study of intravenous granisetron in the treatment of postoperative nausea and vomiting in patients undergoing surgery with general anesthesia.
Taylor AM; Rosen M; Diemunsch PA; Thorin D; Houweling PL
J Clin Anesth; 1997 Dec; 9(8):658-63. PubMed ID: 9438895
[TBL] [Abstract][Full Text] [Related]
15. Prevention of PONV with granisetron, droperidol and metoclopramide in female patients with history of motion sickness.
Fujii Y; Toyooka H; Tanaka H
Can J Anaesth; 1997 Aug; 44(8):820-4. PubMed ID: 9260009
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
[TBL] [Abstract][Full Text] [Related]
17. Preemptive antiemesis in patients undergoing modified radical mastectomy: oral granisetron versus oral ondansetron in a double-blind, randomized, controlled study.
Bhatnagar S; Gupta D; Mishra S; Srikanti M; Singh M; Arora R
J Clin Anesth; 2007 Nov; 19(7):512-6. PubMed ID: 18063205
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blinded comparison of ondansetron, granisetron, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy.
Jain V; Mitra JK; Rath GP; Prabhakar H; Bithal PK; Dash HH
J Neurosurg Anesthesiol; 2009 Jul; 21(3):226-30. PubMed ID: 19543000
[TBL] [Abstract][Full Text] [Related]
19. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Slabý J; Trnený M; Procházka B; Klener P
Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
[TBL] [Abstract][Full Text] [Related]
20. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
